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Case presentation
A 33-year-old man entered the Chulalongkorn University Hospital
because of fever and chills over 5 days. He had been treated symptom-
atically by a local physician without improvement. During the previous
3 days, the patient noticed that his urine was scanty and dark. Two
weeks before the onset of this illness, he had traveled to a rural area
where malaria is endemic.
Physical examination revealed a muscular, acutely ill man with
jaundice. The blood pressure was 124/78 mm Hg; temperature, 39°C;
pulse rate, regular at 112 beats/mm; and respirations, 28/mm. The
patient was somewhat lethargic but communicable; no significant
neurologic signs were present. The sclerae were markedly icteric.
Auscultation revealed a clear chest. The liver was 4 cm below the costal
margin, and the spleen was slightly enlarged. A complete blood count
showed a hemoglobin of 8.7 g/dl; red blood cell count, 3.0 x 106/mm3;
and white blood cell count, 9500/mm3 with 78% neutrophils and 22%
lymphocytes. A peripheral blood smear revealed ring forms of Plasmo-
diumfalciparum in 7% of the erythrocytes. Platelets were 100,000/mm3,
serum haptoglobin was 142 mg/dl, and serum fibrin degradation prod-
ucts were 4.8 mg/dl. Blood chemistry revealed: blood urea nitrogen, 131
mg/dl; serum creatinine, 5.7 mg/dl; uric acid, 10.6 mg/dl; serum sodium,
128 mEq/liter; potassium, 5.2 mEq/liter; bicarbonate, 12 mEq/liter;
chloride, 89 mEq/liter; calcium, 7.2 mg/dl; and phosphorus, 3.8 mgldl.
Liver function tests showed a total bilirubin of 19 mg/dl; direct bilirubin,
13 mg/dl; prothrombin time, 82% of control; serum glutamic oxaloacetic
transaminase, 98 U; glutamic pyruvic transaminase, 80 U; alkaline
phosphatase, 63 IU; serum albumin, 3.8 g/dl; and globulin, 3.2 g/dl.
Serum C3 was 80 mg/dl and plasma fibrinogen was 612 mgldl. The urine
was strongly positive for bilirubin and showed a specific gravity of
1.020, 1 + protein, a pH of 5.8, a few red blood cells, granular casts, and
bilirubin-stained casts. The 24-hour urine volume was 310 ml; urine
osmolality was 301 mOsm/kg H20; urine sodium, 57 mEq/liter; urine
creatinine, 98 mgldl; urine protein, 0.2 g/24 hr; urine uric acid, 120
mg/dl; fractional sodium excretion, 2.6%; and renal failure index, 3.3.
Quinine was given intravenously at a dosage of 1200 mg initially
followed by 600 mg every 8 hours for 24 hours and then at 12-hour
intervals. The degree of parasitemia decreased to 5% the next day, but
the blood chemistry values worsened and the patient became confused.
The BUN rose to 180 mg/dl, the serum creatinine to 7.5 mgldl, and the
serum potassium to 6.2 mEq/liter. Jaundice deepened and oliguria
continued. Hemodialysis was followed by improvement of clinical and
laboratory data; interdialytic increases in BUN and serum creatinine
were always rapid. With quinine administration, the parasitemia disap-
peared on the seventh day of hospitalization. The patient was dialyzed
3 times; diuresis began 15 days after admission. The remaining hospital
course was uneventful, and the patient was discharged 32 days after
admission with a serum creatinine of 1.1 mg/dl.
Discussion
DR. VISITH SITPRIJA (Professor of Medicine, and Chief,
Division of Nephrology, Department of Medicine, Chulalong-
korn University Hospital, Bangkok, Thailand): This patient had
acute renal failure during the course of severe falciparum
malaria. He had heavy parasitemia, cholestatic jaundice, and,
as is characteristic of malaria-induced acute renal failure,
hypercatabolism with rapid rises of blood urea nitrogen and
serum creatinine. The urine uric acid-urine creatinine ratio
exceeded unity, a finding not unexpected in hypercatabolic
acute renal failure with severe jaundice [1]. No evidence of
intravascular hemolysis was present, but low-grade intravascu-
lar coagulation was noted. The clinical data and the clinical
course were consistent with acute tubular necrosis.
Falciparum malaria is one of the common parasitic diseases
causing morbidity and mortality in the tropics. Renal involve-
ment varies widely, from mild proteinuria in the company of
urinary sediment changes to acute renal failure. Electrolyte
abnormalities are often observed as well. I will discuss the
clinical spectrum of renal involvement, renal pathologic
changes, and pathogenesis with an emphasis on acute renal
failure.
Spectrum of renal and electrolyte abnormalities
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Urinary abnormalities. Mild proteinuria and an abnormal
urinary sediment occur commonly in patients with falciparum
malaria without renal failure [2]. Proteinuria is usually less than
1 g/24 hours; abnormal urine findings include a few red blood
cells or white blood cells with occasional granular casts. The
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Table 1. Clinical spectrum of renal and electrolyte abnormalities in
falciparum malaria
Proteinuria with mild urinary sediment changes
Hemoglobinuria
Methemoglobinuria
Abnormal serum electrolytes
Hyponatremia Hyperkalemia
Hypernatremia Hypocalcemia
Hypokalemia Hypophosphatemia
Acute renal failure
Hypercatabolism
Cholestatic jaundice
urinary protein consists of albumin and both macro- and micro-
molecular proteins. Proteinuria is therefore both glomerular and
tubular in origin [3]. Urinary changes usually disappear quickly
when the disease is controlled. This transient proteinuria is
noted in 20% to 70% of patients [4—6]. Renal function usually is
normal in patients with mild proteinuria and minor sediment
changes. Occasionally, moderate proteinuria can be present,
but it resolves during recovery. A nephritic syndrome has been
described, but it is rare [7, 8]. Although persistent nephrotic
syndrome has been reported [91, a cause-and-effect relationship
between malarial infection and the syndrome has not been
substantiated. Interestingly, a strong positive correlation exists
between urinary N-acetyl beta glucosaminidase and the degree
of parasitemia [10]. This relationship indicates subclinical tubu-
lar injury due to renal ischemia that may be related to the
number of parasitized erythrocytes. Hemoglobinuria and met-
hemoglobinuria can be present in association with intravascular
hemolysis (Table 1).
Serum electrolyte alterations. Hyponatremia, usually asymp-
tomatic, is noted in 67% of patients without renal failure and
often is associated with severe infection [11]. This abnormality
is due to multiple factors. Secretion of antidiuretic hormone can
increase [11], perhaps in response to the high fever. In uncom-
plicated malaria, hypervolemia has been observed [12]; Malloy,
Brook, and Barry suggested that the observed increase in
plasma volume was a compensatory response to a decreased
effective circulating blood volume consequent to vasodilation.
The findings are similar to those observed in heat acclimatiza-
tion. Secretion of antidiuretic hormone could result from vaso-
dilation and relative hypovolemia. In some patients, the labo-
ratory findings suggest a "reset" of the osmoreceptor [11].
Sodium accumulates in parasitized as well as nonparasitized
erythrocytes because of decreased sodium-potassium ATPase
activity; the increased accumulation in the erythrocytes may
further contribute to the development of hyponatremia, al-
though quantitatively this factor plays a very minor role [13,
14]. Finally, true sodium depletion rarely is observed. Fluid
administration in malaria should proceed with caution in the
setting of inappropriate secretion of ADH, because fluid over-
load and pulmonary edema can ensue. This can be particularly
problematic in the severely infected patient because of in-
creased vascular permeability in the lung [15, 16]. As antici-
pated, diuretics such as furosemide are useful in this clinical
setting [17]. Hypernatremia is rare, but it has been observed in
cerebral malaria with severe water depletion due to blunted
thirst and inadequate provision of water [6].
Hypokalemia occasionally is observed in uncomplicated ma-
laria and has been attributed to decreased potassium intake and
respiratory alkalosis. Hyperventilation, which often occurs
when high fever is present, results in low plasma pCO2 and
respiratory alkalosis [11]. Hyperkalemia occurs in patients with
intravascular hemolysis or acute renal failure. This complica-
tion can be alarming and requires the same emergency treat-
ment as in any patient with hyperkalemia and acute renal
failure.
Hypocalcemia, independent of renal failure, can be manifest
in severe infection. The cause is not clear, but it might be
related to an intracellular calcium shift [18, 19] and to a low
serum albumin level [20]. Calcium levels in infected erythro-
cytes are elevated; most calcium within the red blood cell is
localized within the parasites [18]. Calmodulin, necessary for
the activation of the calcium pump, is significantly reduced in
schizont-infected erythrocytes. Although such a reduction in
calcium-magnesium ATPase might not be sufficient in the
normal condition to account for the elevation of intracellular
calcium, this reduction of calcium-magnesium ATPase can have
considerable biologic effects in circulating erythrocytes under-
going shear stress [21]. Severe malaria is associated with tissue
anoxia and anaerobic glycolysis; lactic acid production there-
fore is increased [22]. The decreased intracellular pH that
occurs because of lactic acid accumulation can activate the
calcium/hydrogen antiporter and can result in calcium entry
into the cell with hydrogen ion extrusion [23].
Hypophosphatemia can occur in the absence of acute renal
failure, perhaps because of a shift of phosphate into cells from
the accompanying respiratory alkalosis [24]. The urinary phos-
phate is decreased. Insulin secretion, induced by quinine ad-
ministration [25], also shifts phosphate into cells [26]. Nuclear
magnetic resonance spectroscopy has revealed that the inor-
ganic phosphate content in the parasitized erythrocytes is
increased [27].
Acute renal failure. Acute renal failure, one of the dread
complications of falciparum malaria, is observed, as a rule, only
in patients with heavy parasitemia or intravascular hemolysis
with or without glucose-6-phosphate dehydrogenase deficiency
[2]. The diagnosis of blackwater fever should be made only after
glucose-6-phosphate dehydrogenase deficiency has been ex-
cluded. So defined, blackwater fever is no longer common.
Indeed, most of the patients diagnosed as having blackwater
fever in the old days probably had undetected glucose-6-
phosphate dehydrogenase deficiency.
Renal failure can be nonoliguric; its duration ranges from a
few days to several weeks. The overall prevalence of acute
renal failure is less than 1% in falciparum malaria [28], but it
occurs in 60% of patients with severe infection [29]. In our own
experience in an area where malaria is endemic, the prevalence
is 4%; the renal failure usually is seen within 4 to 7 days after
the onset of fever. As noted earlier, patients with malaria-
induced renal failure are hypercatabolic, and blood urea nitro-
gen and serum creatinine levels rise rapidly. Hyperuricemia and
hyperkalemia frequently are present. Hemoglobinuria and met-
hemoglobinuria can occur in the presence of intravascular
hemolysis. Today's patient illustrates the associated hyperca-
tabolism as evidenced by the swift increase in BUN and
creatinine between dialyses. Cholestatic jaundice usually ac-
companies the acute renal failure, and alkaline phosphatase
levels rise out of proportion to the elevation of transaminases,
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as in this patient. Disseminated intravascular coagulation also
can occur [30—32].
Quinine remains the drug of choice for falciparum malaria. In
severe malaria, quinine should be given intravenously. The
loading dose is 16.7 mg/kg followed by 8.4 mg/kg every 8 hours
for 7 days. The dose need not be reduced when renal failure is
mild, that is, if the serum creatinine approximates 3 mg/dl [331.
In patients with more severe renal failure, we use a standard
dose during the first 24 to 48 hours to decrease the parasitemia.
After parasitemia is decreased, the dosage can be reduced to 8.4
mg/kg every 12 to 24 hours for 7 days. The dosage of quinine
needed in severe renal failure requires further study. Dialysis,
when needed, must be performed frequently because of the
hypercatabolism. We prefer hemodialysis; peritoneal dialysis is
less effective than under most other circumstances because of
the impaired peritoneal microcirculation due to parasitized
erythrocytes and vasoconstriction, which result in reduced
solute transport. The efficiency of peritoneal dialysis returns to
normal as parasitemia declines [34, 35]. In developing coun-
tries, peritoneal dialysis continues to be used because of its
technical simplicity and also because of its low cost. Continu-
ous peritoneal dialysis has been performed with good results in
lowering blood urea nitrogen and serum creatinine concentra-
tions [36].
Exchange blood transfusion has been used with good results
in patients with sustained heavy parasitemia or severe hyper-
bilirubinemia (total serum bilirubin greater than 25 mg/dl). This
technique reduces parasitemia, chemical mediators (such as
catecholamine, histamine, and serotonin), and jaundice. Ex-
change blood transfusion thus is an effective adjunctive treat-
ment to dialysis for severe falciparum malaria [31, 37, 38].
Because of the presence of intravascular coagulation and vaso-
constriction in malaria, the use of prostacyclin has been sug-
gested but requires confirmation [39]. Infusion of monoclonal
antibody against a parasite receptor in the vascular endothelium
might have clinical implications in the future treatment of
malaria, but this is speculative at present.
The prognosis of acute renal failure generally is favorable in
patients who have early and frequent dialysis. In our experi-
ence, 60% of patients with malarial renal failure require dialy-
sis, and the mortality has decreased from 30% in the past to less
than 10% at present. The figures are comparable with those
from Stone et al [40]. The prognosis is grave, however, when
multiple organs are involved, especially when acute respiratory
failure is present.
Based on the present understanding of renal pathophysiol-
ogy, prompt antimalarial treatment as well as maintenance of
good urine flow and fluid and electrolyte balance are important
in the prevention of renal failure. The urine should be rendered
alkaline when hemoglobinuria occurs. Since this regimen has
been instituted, the occurrence of renal failure in rural hospitals
in Thailand has decreased. Dopamine and furosemide appear
beneficial in maintaining the renal blood flow and urinary
output. In mild renal failure (serum creatinine less than 5
mg/dl), dopamine and furosemide (given on admission along
with conventional treatment with quinine) prevent further de-
terioration of renal function, shorten the clinical course of renal
failure when compared with a control group receiving only
quinine (with a comparable degree of renal functional impair-
ment), and obviate the need for dialysis (unpublished data,
Sitprija V. Lumlertgul D). In patients with severe renal failure
(serum creatinine greater than 5 mg/dl), the regimen of dopa-
mine and furosemide had no effect on the course of the renal
failure.
Renal pathology
The glomerular histology usually is not remarkable, no matter
what the clinical pattern of malaria. Glomerular hypercellularity
can occur, however. The hypercellularity, often mild, is due to
mononuclear cell infiltration, mesangial hyperplasia, and an
increased mesangial matrix [41]. The glomerular capillaries can
be normal, bloodless, or engorged with erythrocytes. Renal
specimens obtained from patients early in the course of the
disease reveal parasitized erythrocytes and malarial pigment-
laden macrophages in the glomerular capillary loop. Thickening
of the basement membrane is sometimes present. These
changes probably are responsible for the development of mild
proteinuria and urinary sediment changes, but they are not
associated with renal failure; these alterations are mild and
transient and resolve within 4 to 6 weeks, and they do not differ
from changes observed in other acute infections. More severe
glomerular hypercellularity with polymorphonuclear cell infil-
tration can occur occasionally, but it resolves quickly when the
malaria is treated [8].
Immunofluorescent examination discloses granular deposi-
tion of 1gM and C3 in the mesangial areas and along the luminal
side of the glomerular capillaries. In some cases, IgG and IgA
may be detectable. Granular deposition of Plasmodium falci-
parum antigens is demonstrable in the mesangial areas and
along the capillary wall [2].
Electron microscopy reveals electron-dense deposits in the
paramesangial and subendothelial areas. Deformed erythro-
cytes are seen in the space formed by endothelial cytofolds.
Collagen fibrils occasionally are observed in the mesangial
areas. Granular and amorphous materials can be seen in the
inner layer of the basement membrane and subendothelial area
without thickening of the lamina densa or lamina externa [2]. In
one of our studies, we noted that firbin deposition occasionally
occurs in the paramesangial areas [42].
In patients with uncomplicated falciparum malaria who have
mild proteinuria, renal biopsy usually reveals no tubulointersti-
tial changes. In patients with renal failure, tubular changes vary
from unremarkable, mild cloudy swelling and vacuolation [43]
to marked tubular degeneration and necrosis involving most of
the distal tubules, some proximal tubules, and the collecting
ducts [40, 44, 45]. Fine and coarse hemoglobin granules some-
times are present in the proximal tubular cells. Hemoglobin
casts and granular casts often are observed in the lumen of the
distal and collecting tubules. These changes are more striking in
the unusual patient with blackwater fever and in the patient
with intravascular hemolysis. Edema and mononuclear cell
infiltration occur in the interstitium. During the recovery phase,
mitotic activity signifying epithelial regeneration can be prom-
inent in the cells lining the macula densa [2].
In falciparum malaria, the vessels usually are not remarkable.
Deposition of C3 may be visible in the wall of the glomerular
afferent arterioles, but this is a nonspecific finding shared by a
variety of infectious diseases. Renal specimens obtained early
in the course of the disease in patients with heavy parasitemia
demonstrate crowding of peritubular capillaries with parasitized
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tissue. Glomerulonephritis theoretically can be due to in-situ
immune-complex formation, but this phenomenon has not been
shown in humans with falciparum malaria.
Pat ho genesis of acute renal failure
Fig. 1. Various steps of erythrocyte entry by a merozoite.
erythrocytes. Malarial pigment-laden macrophages, lympho-
cytes, plasma cells, and fibrin thrombi also are seen [291.
Adherence of parasitized erythrocytes to the endothelial cells
has been revealed by electron microscopy [46]; this could be an
important cause of renal ischemia and renal failure.
Patho genesis
Patho genesis of glomerular lesions
Mild glomerular changes in falciparum malaria clearly are
caused by immunologic mechanisms. The soluble antigens of P.
falciparum are detectable in circulating immune complexes and
in the glomeruli [8, 41, 47]. Serum C3 and C4 may be decreased
during the acute phase of the disease. In our unpublished
experience, this is observed in approximately 50% of cases.
Glomerulonephritis in falciparum malaria therefore appears to
be immune-complex in type. It is transient and, like many other
acute postinfectious glomerulonephritides, it is associated with
rapid clearing of immune-complex deposition. In Plasmodium
berghei infection in mice, which corresponds to falciparum
malaria in humans, free plasmodium antigens can be detected in
the glomeruli without immunoglobulin deposition [48, 491.
Antigen deposition is related in this model to the degree of
parasitemia; this finding raises the possibility of primary phys-
ical interaction or adherence of malarial antigens to the renal
Two mechanisms are involved in the pathogenesis of renal
failure in falciparum malaria: effects of parasitized erythrocytes
and nonspecific inflammatory effects.
Parasitized erythrocytes and hemorrheologic changes. Entry
of merozoites into erythrocytes requires formation of a junction
between the erythrocyte membrane and the apical end of the
merozoite (Fig. 1). Migration of the junction parallel to the long
axis of the merozoite brings the merozoite into an invagination
of the erythrocyte. The erythrocyte receptors recognized by the
malarial parasites are believed to be glycoproteins [50, 51].
Alterations in the membrane of the infected erythrocytes form
electron-dense protrusions, or knobs [52, 53]. A few knobs
occur in the membrane of the erythrocyte infected with the ring
form; the number of knobs increases as the parasite matures.
These knobs can adhere to the vascular endothelial cells or to
the knobs of other erythrocytes [54, 55]. The precise mecha-
nism of endothelial cytoadherence is not clear. The endothelial
cytofolds may enhance erythrocyte trapping. The receptor of
this binding protein is thought to be thrombospondin, a 450—500
kDa glycoprotein. Of interest is the fact that only P. falciparum-
infected erythrocytes bind to the endothelial cells of the capil-
laries and venules (Fig. 2). P. malariae- and P. vivax-infected
erythrocytes do not have this property [56]. Therefore, inter-
ference with the microcirculation is an important pathophysio-
logic change in falciparum malaria. When these knobs appear
on the erythrocyte membrane, the trophozoite-infected cells
retreat from the peripheral circulation and are sequestered in
the venules and capillaries of various organs. Impedance of the
microcirculation by endothelial cytoadherence and the rapid
multiplication of parasites in falcipartim malaria make renal
failure common in falciparum malaria, as opposed to its rare
occurrence in the other malarias.
Parasitized erythrocytes have decreased deformability.
Rheoscopy of parasitized erythrocytes reveals impaired deform-
ability at physiologic shear stresses and shows that the eryth-
rocytes recover their normal shape slowly [57]. Erythrocytes
containing more mature parasites exhibit no deformability at
all. Loss of deformability increases with maturity of parasites in
the erythrocytes, causing the sluggish flow in the microcircula-
tion. Acute-phase proteins, especially fibrinogen, are increased(as in this patient), and account for the increased plasma
viscosity. Erythrocyte viscosity also is increased because of
rigidity of the infected erythrocytes; the whole-blood viscosity
thus is increased and contributes further to the slow flow in the
microcirculation.
Nonspecific effects of infection. Several pathophysiologic
alterations that occur in falcipanim malaria can lead to renal
ischemia and tubular injury. These alterations are the nonspe-
cific consequences of infection, but they are important factors
in the pathogenesis of renal failure.
(a) Hypovolemia. Blood volume determination in falciparum
malaria has yielded conflicting results depending on the stage of
infection and on fluid administration. Hypervolemia attributed
to systemic vasodilation with fluid retention has been described
in uncomplicated falciparum malaria [12, 58]. Patients with
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Fig. 2. Knobs on the parasitized erythrocyte membrane (arrows) adhere to the glomerular endothelium (EN). (Courtesy of Dr. V. Boonpucknavig;
magnified x 30,500.)
renal failure have been reported to be normovolemic [43], but
these patients received fluid prior to blood volume determina-
tion. In induced malaria in humans, hypovolemia occurred
initially and was followed by hypervolemia and normovolemia
[59]. Hypovolemia developed in a group of patients with renal
failure who received no fluid prior to the study [601.
What do these data mean? I believe that in uncomplicated
malaria, hypervolemia occurs due to vasodilation and fluid shift
from cells; this change is similar to what is seen in heat
exposure. Antidiuretic hormone release in uncomplicated ma-
lana contributes to water retention and hyponatremia. In severe
infection, vascular permeability is increased by chemical medi-
ators including kinins, prostaglandins, leukotrienes, histamine,
serotonin, adenosine, and probably other unidentified sub-
stances [61—63]. Fluid leaks from the intravascular compart-
ment and leads to hypovolemia. Vascular endothelial damage—
induced by anoxia, complement activation, and oxygen radicals
released during the inflammatory process [64] and circulatory
reflow [651—further increases fluid leakage from the intravas-
cular space. Blood volume thus decreases in severe infection,
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and this decline in volume is further compounded by decreased
fluid intake and increased fluid loss through the skin and
respiration.
(b) Intravascular coagulation. Alterations in coagulation
factors, prolonged prothrombin time, thrombocytopenia, and
the presence of fibrin degradation products are common in
severe falciparum malaria [66—69]. The fibrinogen half-life is
diminished [67], and fibrin can be deposited in the vascular bed
[69]. Occasionally, disseminated intravascular coagulation oc-
curs in severe cases and is associated with cerebral, pulmonary,
and renal complications [30—32]. Cerebral malaria, acute respi-
ratory failure, and renal failure are well known in severe
malaria. In most patients, however, the classic picture of
disseminated intravascular coagulation is not present, and fibrin
deposition in the glomeruli is infrequent. Generally only re-
gional or low-grade intravascular coagulation is present, and its
contribution to the development of renal failure is probably
minimal.
(c) Intravascular hemolysis. Several factors including mem-
brane changes [70, 71], immunologic reactions [72, 73], altera-
tion of charges on the erythrocyte surface 123, 74], and inter-
ference with erythrocyte ATP and sodium-potassium ATPase
[13, 75] have been incriminated in causing hemolysis. Yet,
except for patients with glucose-6-phosphate dehydrogenase
deficiency or those receiving multiple drug treatment (which is
common in the tropics), hemolysis is often mild and usually
extravascular. Blackwater fever therefore is rare if one rigidly
excludes patients with glucose-6-phosphate dehydrogenase de-
ficiency. In the majority of cases, hemoglobin cannot be de-
tected in the plasma, and serum haptoglobin, as in today's
patient, is normal.
(d) Catecholamine effects. There is good evidence for cate-
cholamine release both in animal and human malarias. Constric-
tion of the splanchnic blood vessels has been demonstrated in
the animal model; dilation of these vessels was achieved with
the administration of phenoxybenzamine [761. During the early
phase of acute renal failure in human malaria, decreased urine
flow, a low urine sodium concentration, low creatinine clear-
ance, and high urine osmolality have been observed. In 2
patients, phenoxybenzamine injection increased urine flow,
urine sodium, and creatinine clearance [77]. These findings
indicate increased catecholamine activity. Catecholamine re-
lease is attributed to sympathetic stimulation arid stimulation of
the adrenal gland by kinin [78]. Catecholamines, along with
renin-angiotensin activation by hypovolemia, contribute to the
decreased renal blood flow [60] and also participate, by leu-
kocyte-mediated activation of the kallikrein-kinin system, in
increasing vascular permeability [79]. Catecholamines also can
directly increase vascular permeability [80]. In infected mice,
catecholamines probably play a role in the development of
pulmonary edema because phenoxybenzamine administration
can prevent pulmonary edema [811.
(e) Endoloxemia. The clinical manifestation of malaria resem-
bles septicemia and endotoxemia. Although malarial toxins
could not be identified, bacterial endotoxin has been detected in
some patients [82]. Gram-negative bacteria have been isolated
from the blood of patients with severe malaria. Vascular stasis
in the gut and failure of hepatic clearance of the absorbed
endotoxin from the gastrointestinal tract are the possible causes
of endotoxemia. Although a direct toxic effect on the renal
Table 2. Multiregression analysis of risk factors in the development
of acute renal failure in falciparum malariaa
Factor Coefficient P Value
Hypovolemia 2.44 <0.025
Heavy parasitemia 4.21 <0.01
Blood hyperviscosity 4.21 <0.01
Jaundice 4.17 <0.01
Intravascular hemolysis 1.38 >0.05
Intravascular 1.04 >0.05
coagulation
a The analysis is based on our data from 20 malarial patients with
renal failure and 20 malarial patients without renal failure. (Unpublished
observations.)
tubules has not been described, endotoxin increases the isch-
emic renal injury [83]. Recently, cytokines have been impli-
cated in various mechanisms in the inflammatory process [84].
Cytokines can activate polymorphonuclear cells (thus promot-
ing adhesion of neutrophils to the endothelial cells), exert
procoagulant activity, increase expression of thrombomodulin,
cause fever, and increase protein catabolism and depression of
membrane potential in the muscle fiber. Injection of the cyto-
kine cachectin in rats induces hemoconcentration, shock, and
acute tubular necrosis [85]. Clark has suggested that cytokines
are important in the production of endotoxin-like effects in
malaria [86, 87].
(f) Jaundice. Although mild jaundice does not have an
injurious effect on the kidney, severe jaundice can adversely
affect renal function. The mechanism is not clear. Jaundice
increases the vascular response to catecholamine [88], in-
creases plasma renin activity [89], and induces hyperuricosuria
[90]. It therefore is not surprising to see the urine uric acid-to-
urine creatinine ratio above one in hypercatabolic and hyper-
bilirubinemic acute renal failure [1], as in the patient we are
discussing. Natriuresis with failure to conserve sodium in
response to sodium restriction has been observed in patients
with obstructive jaundice when the total serum bilirubin ex-
ceeds 25 mg/dl [91]. Hemodynamic studies have demonstrated
decreased left-ventricular function in severe jaundice, which in
turn might play a role in the decline in renal function [92, 93].
Jaundice is invariably present in severe falciparum malaria with
renal failure, so it could contribute to compromised renal
function. The improvement of renal function following ex-
change blood transfusion supports the adverse renal effects of
severe jaundice.
All these nonspecific factors are shared by various infections
[941 and are known to play a role in the pathogenesis of acute
renal failure in malaria. Statistical analysis of the data compar-
ing patients with and without renal failure discloses that heavy
parasitemia, blood hyperviscosity, jaundice, and hypovolemia
are the critical predisposing factors (Table 2). Renal failure in
malaria therefore is due to multiple factors, as shown in Figure
3. Oxygen radicals and complement activation, either by clas-
sical or alternative pathway [95, 96], can contribute further to
the cellular injury. In the animal model, renal tubular injury also
can be induced by hyperpyrexia [971, and oxygen radicals as
well as complement activation may be incriminated [98]. Alter-
ations in T-cell function in severe malarial infection [99],
especially natural killer cells through decreased interleukin-2
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production [100], could impair eradication of malarial parasites,
favor secondary infection, and lead to further renal compro-
mise.
Questions and answers
DR. JOHN T. HARRINGTON (Chief of Medicine, Newton-
Wellesley Hospital, Newton, Massachusetts): Thank you very
much, Dr. Sitpnja, for your comprehensive review of renal
dysfunction in falciparum malaria. Could you comment further
on the interrelationship among glucose-6-phosphate dehydroge-
nase deficiency, malarial infection, and drug treatment? I am
especially interested in knowing whether the glucose-6-phos-
phate-dehydrogenase-deficient erythrocyte is more or less sus-
ceptible to malarial infection than is a normal erythrocyte.
Second, is the red cell deficient in glucose-6-phosphate dehy-
drogenase more susceptible than a normal red cell to hemolysis
after being infected by malaria?
DR. SITPRIJA: Glucose-6-phosphate-dehydrogenase-deficient
erythrocytes are more resistant to malarial infection. They
generally are invaded by the parasites, but maturation of
intracellular parasites is delayed and impaired by metabolic
changes [101]. Yet, glucose-6-phosphate-dehydrogenase-de-
ficient erythrocytes are more susceptible to hemolysis. In
glucose-6-phosphate-dehydrogenase deficiency, reduced gluta-
thione cannot be formed because the ability of NADH in the
hexose monophosphate shunt to be reduced is impaired. He-
molysis is not noticeable until the individual is exposed to an
oxidant stress induced by infections or drugs. The hemolysis is
attributed to oxidant damage of erythrocyte membrane and
hemoglobin, the process that is usually protected by the pres-
ence of reduced glutathione. Glucose-6-phosphate-dehydroge-
nase-deficient erythrocytes therefore are more susceptible to
hemolysis when infected by malaria than are infected erythro-
cytes with normal glucose-6-phosphate dehydrogenase.
DR. JORDAN J. COHEN (Dean of Medicine, State University
of New York at Stony Brook, Stony Brook, New York): How
effective are the current epidemiologic and public health mea-
sures in reducing the frequency of malaria?
DR. SITPRIJA: According to the recent report of the Thailand
Ministry of Health, the incidence of malaria in Thailand has
decreased from 1,000 per 100,000 population in 1981 to 550 per
100,000 in 1986, and the mortality rate has dropped from 9 per
100,000 to 3 per 100,000. The incidence of renal failure also has
declined in provincial hospitals.
DR. COHEN: Given the adequacy of current supportive mea-
sures for acute renal failure, why do some patients with
falciparum malaria die?
DR. SITPRIJA: They die of multiple organ involvement, espe-
cially acute respiratory failure, cerebral malaria, and superim-
posed bacterial infection.
DR. HARRINGTON: I am interested in your observation that a
combination of dopamine and furosemide seems to abort the
development of full-blown acute renal failure, at least in pa-
tients treated early in the course of the disease. Could you
provide us with more details regarding the design of the study
and the numbers of patients involved? Specifically, were the
patients randomly allocated to a control group, to treatment
with furosemide alone, or to treatment with furosemide and
dopamine?
DR. SITPRuA: The patients under study had serum creatinine
levels ranging from 2.6 mg/dl to 4.5 mg/dl with urinary indices
compatible with acute tubular necrosis. The patients were
randomly allocated into 3 groups with 4 patients in each group.
The control group received only quinine, the second group
received quinine and furosemide (200 mg intravenously at
6-hour intervals), and the third group received quinine and
furosemide (200 mg intravenously at 6-hour intervals) with
dopamine (1 tgIkg/min intravenously). All groups were
matched with respect to age, duration of onset of fever, degree
of parasitemia, serum creatinine, and clinical features. The
study was performed in a controlled and prospective fashion.
Furosemide and dopamine were given on the second hospital
day, which was 6 to 8 days after the onset of fever. The serum
creatinine continued to rise in controls and in the second group,
but it remained stable in the third group, who received furose-
mide and dopamine.
DR. NICOLAOS E. MADIAS (Chief, Division of Nephrology,
New England Medical Center, Boston, Massachusetts): I was
particularly intrigued by the information you provided on the
parasitic invasion of erythrocytes by binding to specific recep-
tors on the erythrocytic surface. I have several questions about
this. Does the virulence of various strains of P. falciparum
relate to specific receptor requirements for invasion of erythro-
cytes? Does nature employ the strategy of depleting erythro-
cytes of those receptors, thus conferring resistance against
parasitization? What is the basis of resistance against malaria
associated with various hemoglobinopathies, such as sickle-cell
anemia and thalassemia?
DR. SITPRIJA: Certainly the severity of infection is related to
the number of receptors on erythrocytes. However, the viru-
lence of the parasite should be viewed in light of the intrinsic
property of the parasite itself with respect to the surface charge
and the receptor in the parasitic membrane. It is speculated that
decreased negative charges could bring the parasite close to the
receptor on the erythrocyte and could enhance penetration
[102].
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Depletion of receptors on the erythrocyte by trypsin de-
creases parasitic invasion [103]. Monoclonal antibody against
the trypsin-sensitive portion of the receptor has resulted in
marked inhibition of invasion [103]. It is, however, not known
whether nature employs this mechanism to induce parasitic
resistance.
In sickle-cell hemoglobinopathy, low oxygen tension during
sequestration of infected erythrocytes in the venous environ-
ment and the decreased pH of infected erythrocytes cause the
hemoglobin S-containing host cells to sickle. The host cell
plasma membrane thus becomes leaky to potassium and causes
potassium loss and death of parasites [104]. In thalassemia, the
erythrocytes also are unfavorable to the growth of parasites.
The erythrocytes are sensitive to oxidant stress, which causes
membrane damage, potassium leakage, and death of the para-
sites [105]. Phagocytosis of these cells is also increased.
DR. DUSTT LUMLERTGUL (Assistant Professor of Medicine,
Chiang Mai Hospital, Chiang Mai, Thailand): Do you think
that cachectin plays a role in the pathogenesis of malarial
infection?
DR. SITPRIJA: Recent evidence indicates that it does. Endo-
toxemic symptoms and pathologic changes seen in malaria—
including hypotension, hypoglycemia, hypertriglyceridemia,
hepatic necrosis, renal tubular necrosis and pulmonary accu-
mulation of neutrophils—can be induced by cachectin injection.
Mice with experimental malaria are more susceptible than are
normal mice to injected cachectin; this finding implies the
functional significance of cachectin in malaria [871.
Da. HARRINGTON: Are blockers of cachectin available? If so,
do they protect against the development of acute tubular
necrosis in the rat?
DR. SrrpauA: That is an interesting question in view of the
finding that passive immunization against cachectin in mice
protects animals from the lethal effect of endotoxin [106]. I do
not know of any data on malarial renal failure. However, in a
recent study in mice with malaria induced by P. berghei, prior
injection of cachectin antibody protected against cerebral ma-
lana without modifying the parasitemia. Cerebral vessels
showed no lesions, as opposed to the control animals with focal
accumulation of packed mononuclear cells containing infected
erythrocytes [107]. Theoretically, because renal failure in ma-
laria is due to multiple mechanisms, cachectin antibody would
offer only partial protection.
DR. COHEN: Can P. falciparum invade any cells other than
erythrocytes?
DR. SITPRLJA: I don't believe so, except for liver cell invasion
by sporozoites during the initial stage of infection.
DR. KRIANG TUNGSANGA (Assistant Professor of Medicine,
Chulalongkorn Hospital): Malarial parasites have been found in
platelets. The mechanism of penetration is not clear [108].
DR. MADIAS: Are chioroquine-resistant strains of P. falcipa-
rum different from those sensitive to chloroquine in terms of
inducing acute renal failure?
DR. SITPRIJA: I am not aware of any data demonstrating a
difference in inducing renal ischemia between the two strains.
DR. SUCHATI INDRAPRASIT (Professor of Medicine, Rama-
thibodi Hospital, Bangkok): Dr. Sitprija, you proposed that
hypovolemia due to increased vascular permeability is one of
the causes of renal failure in malaria. I would like to know about
fluid administration in this setting.
DR. SITPRIJA: Your question is quite relevant. Hypovolemia
should be corrected by normal saline. Because there is evidence
of inappropriate secretion of ADH in malaria, however, fluid
administration must be handled with caution to avoid fluid
overload and pulmonary edema. Adult respiratory distress
syndrome is one of the dread complications in severe malaria.
With adequate urine flow, fluid can be administered at ease. If
there is no urinary response to fluid load within 6 hours, I use a
combination of furosemide and fluid administration.
DR. COHEN: If one could block the adherence of the parasite
to endothelia, how might the clinical manifestation of the
disease be altered? Is such blockage feasible?
DR. SITPRIJA: Adherence of the parasite to the endothelial
cells can be blocked by the use of thrombospondin antibody.
Although this has been tried in animals [54], it has not yet been
used in humans. Conceivably blockade of cytoadherence could
be of great benefit if both cachectin and thrombospondin could
be blocked.
DR. COHEN: As you noted, thrombospondin is the endothelial
receptor for the "knob" on erythrocytes infected with P.
falciparum. Does thrombospondin have any known physiologic
function or pathophysiologic significance in any other diseases?
DR. SITPRIJA: Thrombospondin is secreted in the alpha
granules of platelets, by several mesenchymal cells, and by
mesangial cells. It binds many constituents of plasma as well as
cellular and extracellular matrix elements. Heparin, type-V
collagen, fibrinogen, laminin, fibronectin, von Willebrand fac-
tor, histidine-rich glycoprotein, and plasminogen also show
specific affinities for thrombospondin. Thrombospondin secre-
tion by smooth muscle cells can be stimulated by platelet-
derived growth factor. Thrombospondin plays a role in regulat-
ing the proliferative response of smooth muscle cells to injury,
and it might be significant in the pathogenesis of glomerular
disease with mesangial proliferation and matrix expansion
[105].
DR. HARRINGTON: Could you quantitate the immunofluores-
cent deposition of P. falciparum antigens in renal tissue and
correlate that observation with the severity of renal failure?
DR. SITPRIJA: On theoretical grounds, more malarial antigens
should be found ih the kidneys of patients with severe renal
failure. But because renal biopsy usually is performed late in
the course of the disease, no correlation between the amount of
antigen deposition and the severity of renal failure has been
observed.
DR. COHEN: Does respiratory alkalosis occur any more
commonly in falciparum malaria than in other illnesses with
comparable degrees of fever, or is the alkalosis simply a
nonspecific consequence of fever?
DR. SITPRIJA: The occurrence is the same in malaria as in
other febrile diseases. I believe that it is a nonspecific effect of
fever.
DR. SAUWALUCK CHUSIL (Assistant Professor of Medicine,
Chulalongkorn Hospital, Bangkok): The duration between the
onset of malarial infection and the development of glomerulo-
nephritis is short, and glomerulonephritis seems similar to acute
serum sickness. Have you ever seen severe glomerulonephritis
in acute malaria? Have you studied the glomerular pathology of
chronic malarial infection?
Da. SITPRIJA: We have not seen severe glomerulonephritis in
falciparum malaria, and I doubt its existence. In previous
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reports of persistent nephritis, a cause-and-effect relationship
was not shown. We have not studied the glomerular change in
repeated malarial infection. On clinical grounds, there is no
evidence of glomerulonephritis in those patients.
DR. COHEN: Given that patients who contract falciparum
malaria are likely at risk for re-exposure to the parasite, how
common is recurrent disease? Do patients develop effective
immunity?
DR. SITPRuA: Immunity to malaria is of short duration,
lasting from 3 to 6 months. However, subsequent infections
usually do not produce as high a degree of parasitemia as that in
the original infection.
DR. ANUCHIT CHUTAPUTTI (Medical Resident, Pramong-
kutklao Army Hospital, Bangkok): Why is the patient with
severe malaria and heavy parasitemia often muscular?
DR. SITPRIJA: I am not sure that this observation is always
true. It is, however, interesting that in P. berghei infection,
calorie-deficient rats have significantly lower parasitemia than
do well-fed animals [1091. The explanation for this is not clear,
but the findings suggest interactions of protein calorie malnu-
trition and immune response in malaria. How this finding in
animals correlates with some of the observations in humans, I
am not certain.
DR. COHEN: You noted that sodium-potassium ATPase ac-
tivity is diminished in erythrocytes infected with P. falciparum.
Does this alteration contribute to hemolysis?
DR. SITPRIJA: Yes, diminished sodium-potassium ATPase is
one of several factors that contribute to hemolysis. Accumula-
tion of sodium in excess of potassium loss is associated with a
gain in cell water and swelling of the erythrocyte. Abnormal ion
transport in the erythrocyte is recognized as a feature of several
forms of hemolytic anemia, including malaria.
Reprint requests to Dr. V. Sitprija, Chulalongkorn University Hos-
pital, Bangkok 10500, Thailand
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